Key Takeaways:
- Bayer is accelerating camelina production to 2 million North American acres
- The Iran war energy crunch is making biofuels economically viable sooner
- A BP alliance and crushing deal aim to secure farmer adoption and offtake
Back
Bayer accelerates camelina biofuel plan to 2M acres amid Iran war
Bayer is racing to scale camelina production across 2 million North American acres as the Iran war reshapes global energy economics.
Bayer is accelerating plans to produce camelina across a couple of million acres in North America, betting the Iran war-driven energy crunch will make biofuels economically viable years ahead of schedule.
"Those decisions were taken in a different context. Now it's about ramping things up even quicker," Peter Muller, Bayer's global head of cereals, cotton and canola, said at the International Grains Council conference in London.
The Germany-based crop science giant last month formed an alliance with BP to commercialize camelina for biodiesel, renewable diesel and sustainable aviation fuel. Bayer had originally targeted the mid-2030s for its acreage goal but now expects to reach it earlier, Muller said. The company is also finalizing a deal with a North American crushing firm to guarantee farmers a buyer for their crop.
The push shows how geopolitical instability is reshaping the economics of alternative fuels. Biofuels become more competitive when fossil fuel prices rise, and the Iran war has pushed crude prices sharply higher, narrowing the cost gap with petroleum-based fuels and accelerating corporate investment in second-generation feedstocks.
Why Camelina, and Why Now
Camelina is an intermediate oilseed crop that can be grown between main planting seasons or on underutilized land, meaning it does not directly compete with food production — a key advantage over first-generation biofuels made from corn or sugar that have drawn criticism for driving up food prices and deforestation. The crop's oil content makes it suitable for conversion into renewable diesel and sustainable aviation fuel, two markets facing surging demand as airlines and trucking fleets seek lower-carbon alternatives.
The Iran war has supercharged that demand. Crude prices have surged since the conflict began, making biofuel blends more cost-competitive at the pump and in jet fuel tanks. For Bayer, the shift represents an opportunity to expand its crop science business beyond traditional row crops into the energy supply chain, a market that could reach tens of billions of dollars as governments tighten emissions mandates.
The Farmer Economics
Bayer's strategy hinges on farmer adoption. By securing a crushing partner — a facility that processes camelina seeds into oil and meal — the company aims to remove the biggest barrier to entry: the fear of planting a crop with no guaranteed buyer. Muller said the deal is close to closing, though he declined to name the firm.
The approach mirrors how Bayer and other agribusinesses have scaled new crops in the past: secure the processing infrastructure first, then build grower contracts. If successful, the North American model could be replicated in other regions. "We're in the process of evaluating expansion in other geographies," Muller said.
For investors, the accelerated timeline signals that Bayer sees biofuels not as a niche experiment but as a meaningful growth driver for its crop science division. The company's alliance with BP also provides a built-in offtake channel, with the energy major using camelina oil to meet its own renewable fuel blending obligations.
This article is for informational purposes only and does not constitute investment advice.
